| Literature DB >> 26385816 |
Aziz K Valika1, Dhanpat Jain1, Phillip E Jaffe2, Gilbert Moeckel1, Ursula C Brewster3.
Abstract
A 63-year-old man with HIV (human immunodeficiency virus) infection and end-stage renal disease, treated with lanthanum carbonate phosphate binder for 4 years, presented with anemia and an upper gastrointestinal bleed. Upper endoscopy revealed a nodular hyperplastic epithelium, with an endoscopic ultrasound confirming hyperechoic material within the nodules. Light microscopy showed collections of histiocytes and multinucleated giant cells containing brown granular cytoplasmic material and extracellular crystalline material, a finding confirmed by electron microscopy. Similar pathologic findings associated with lanthanum exposure have been described recently. In our patient, lanthanum carbonate treatment was withdrawn and gastrointestinal bleeding has since ceased. The patient was exposed to a high amount of lanthanum over a long period, which may explain his adverse reaction. However, other contributing factors, such as competing medications or comorbid conditions, also may have increased his sensitivity to the drug.Entities:
Keywords: Lanthanum carbonate; dialysis; end-stage renal disease (ESRD); foreign-body reaction; histiocytosis; hyperphosphatemia; phosphate binder; upper gastrointestinal bleed
Mesh:
Substances:
Year: 2015 PMID: 26385816 DOI: 10.1053/j.ajkd.2015.07.033
Source DB: PubMed Journal: Am J Kidney Dis ISSN: 0272-6386 Impact factor: 8.860